Skip to main content
BIOMARIN PHARMACEUTICAL INC logo

BIOMARIN PHARMACEUTICAL INC — Investor Relations & Filings

Ticker · BMRN ISIN · US09061G1013 LEI · NSLL8ITTRR0J5HEMR848 US Manufacturing
Open in API
Filings indexed 1,868 across all filing types
Latest filing 2026-06-04 Declaration of Voting R…
Country US United States of America
Listing US BMRN

About BIOMARIN PHARMACEUTICAL INC

https://www.biomarin.com/

BioMarin Pharmaceutical Inc. is a global biotechnology company that develops and commercializes therapies for rare, life-threatening genetic diseases. The company focuses on translating genetic discoveries into new medicines, with a core expertise in enzyme replacement therapies (ERTs). Its portfolio includes eight marketed products for conditions such as achondroplasia, severe hemophilia A, and various lysosomal storage diseases. In addition to its commercialized treatments, BioMarin maintains a pipeline of investigational medicines in various stages of clinical and preclinical development, aiming to create first-in-class and best-in-class therapeutics.

Recent filings

Filing Released Lang Actions
8-K
Declaration of Voting Results & Voting Rights Announcements Classification · 90% confidence This is a Form 8-K current report describing the results of matters submitted to a vote of security holders (Item 5.07) and changes in director/equity plan approval (Item 5.02). It provides detailed voting tallies for each proposal from the Annual Meeting. This matches the definition for Declaration of Voting Results & Voting Rights Announcements (DVA).
2026-06-04 English
10-Q - BIOMARIN PHARMACEUTICAL INC (0001048477) (Filer)
Interim / Quarterly Report Q1 2026
2026-05-05 English
8-K - BIOMARIN PHARMACEUTICAL INC (0001048477) (Filer)
Report Publication Announcement Classification · 85% confidence The document is a Form 8-K current report (Item 2.02: Results of Operations and Financial Condition) that merely announces and furnishes an earnings press release as Exhibit 99.1. It is under 5,000 characters and explicitly states that the press release is attached. Per the “menu vs. meal” rule, this is not the earnings release itself but an announcement that a report has been published and is attached. This fits the definition of a Report Publication Announcement (RPA).
2026-05-04 English
8-K - BIOMARIN PHARMACEUTICAL INC (0001048477) (Filer)
M&A Activity Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a Current Report used to announce major events that shareholders should know about. The content describes the completion of a merger transaction, entry into a material definitive agreement (merger agreement), creation of new credit facilities, and related financial obligations. It also references exhibits including the merger agreement and credit agreement. The document is not a full annual or quarterly report, nor is it an earnings release or proxy statement. It is primarily an announcement of a merger and related financing activities. Therefore, the most appropriate classification is 'M&A Activity' (TAR), which covers announcements and documents related to merger proposals or takeover bids. The document length and detail support this classification with high confidence.
2026-04-27 English
8-K - BIOMARIN PHARMACEUTICAL INC (0001048477) (Filer)
M&A Activity Classification · 100% confidence The document is a Form 8-K Current Report filed with the SEC, dated April 23, 2026. It announces a significant event related to a merger agreement between BioMarin Pharmaceutical Inc. and Amicus Therapeutics, Inc. The content focuses on the regulatory clearance received for the merger and the expected closing date. There are no financial statements or detailed financial analysis included, only an update on the merger process and regulatory approval. This type of filing is best classified under M&A Activity (TAR) as it relates to merger announcements and related regulatory updates.
2026-04-23 English
ARS - BIOMARIN PHARMACEUTICAL INC (0001048477) (Filer)
Annual Report
2026-04-21 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.